Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3FZ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,887
Award facts
- Contract value 100% obligated
- $21,886.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,886.51 firm fixed-price delivery order to Amerisourcebergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials, with an ultimate completion date of January 29, 2026. This non-set-aside contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc., doing business as Amerisourcebergen, is a major pharmaceutical distributor serving federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
This delivery order exemplifies the company's critical role in supporting military healthcare supply chains by providing brand-name pharmaceutical products across multiple therapeutic domains. The contract leverages the comprehensive pharmaceutical prime vendor framework, which enables efficient procurement of diabetes medications and other essential pharmaceuticals needed by military treatment facilities and veteran healthcare programs worldwide. As a competitively awarded contract without set-aside restrictions, this award reflects Amerisourcebergen's capability to meet federal procurement standards through open competition and its established position as a key supplier within the DLA's global pharmaceutical support network.
Quick answers
Who was awarded contract SPE2DR26F3FZ9?
SPE2DR26F3FZ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F3FZ9 worth?
The government has obligated $21,887 on SPE2DR26F3FZ9.
Is contract SPE2DR26F3FZ9 an order under another contract?
Yes. SPE2DR26F3FZ9 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3FZ9 competed?
The extent of competition for SPE2DR26F3FZ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award